Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelli...
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
The United States Preventive Services Task Force supports individualised decision-making for prostate-specific antigen (PSA)-based screening in men aged 55-69. Knowing how the potential benefits and harms of screening vary by an individual's risk of developing prostate cancer could inform decision-making about screening at both an individual and po...
Alternative Titles
Full title
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2339843618
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2339843618
Other Identifiers
ISSN
1549-1676,1549-1277
E-ISSN
1549-1676
DOI
10.1371/journal.pmed.1002998
